News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
289,045 Results
Type
Article (13271)
Company Profile (85)
Press Release (275689)
Multimedia
Podcasts (11)
Webinars (10)
Section
Business (84223)
Career Advice (2531)
Deals (13837)
Drug Delivery (32)
Drug Development (29581)
Employer Resources (115)
FDA (8672)
Job Trends (8220)
News (140869)
Policy (13673)
Tag
Academia (1523)
Accelerated approval (1)
Adcomms (8)
Allergies (51)
Alliances (21094)
ALS (35)
Alzheimer's disease (600)
Antibody-drug conjugate (ADC) (50)
Approvals (8729)
Artificial intelligence (141)
Autoimmune disease (8)
Automation (10)
Bankruptcy (101)
Best Places to Work (7292)
BIOSECURE Act (2)
Biosimilars (52)
Biotechnology (50)
Bladder cancer (55)
Brain cancer (23)
Breast cancer (193)
Cancer (1254)
Cardiovascular disease (94)
Career advice (2098)
Career pathing (34)
CAR-T (55)
Cell therapy (168)
Cervical cancer (16)
Clinical research (25573)
Collaboration (419)
Compensation (142)
Complete response letters (2)
COVID-19 (1026)
CRISPR (14)
C-suite (175)
Cystic fibrosis (39)
Data (1184)
Decentralized trials (2)
Denatured (7)
Depression (18)
Diabetes (147)
Diagnostics (4151)
Digital health (13)
Diversity (5)
Diversity, equity & inclusion (34)
Drug discovery (39)
Drug pricing (41)
Drug shortages (5)
Duchenne muscular dystrophy (43)
Earnings (25899)
Editorial (14)
Employer branding (13)
Employer resources (104)
Events (41785)
Executive appointments (564)
FDA (9459)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (4)
Funding (401)
Gene editing (30)
Generative AI (11)
Gene therapy (134)
GLP-1 (194)
Government (2503)
Grass and pollen (2)
Guidances (63)
Healthcare (12629)
Huntington's disease (3)
IgA nephropathy (19)
Immunology and inflammation (38)
Indications (19)
Infectious disease (1082)
Inflammatory bowel disease (52)
Inflation Reduction Act (4)
Influenza (20)
Intellectual property (29)
Interviews (428)
IPO (5511)
IRA (10)
Job creations (1221)
Job search strategy (1790)
Kidney cancer (2)
Labor market (30)
Layoffs (143)
Leadership (21)
Legal (2450)
Liver cancer (39)
Lung cancer (180)
Lymphoma (94)
Machine learning (4)
Management (40)
Manufacturing (113)
MASH (16)
Medical device (8213)
Medtech (8216)
Mergers & acquisitions (8645)
Metabolic disorders (252)
Multiple sclerosis (34)
NASH (5)
Neurodegenerative disease (28)
Neuropsychiatric disorders (9)
Neuroscience (820)
NextGen: Class of 2025 (4157)
Non-profit (3777)
Now hiring (38)
Obesity (95)
Opinion (107)
Ovarian cancer (39)
Pain (36)
Pancreatic cancer (34)
Parkinson's disease (57)
Partnered (7)
Patents (81)
Patient recruitment (62)
Peanut (29)
People (32694)
Pharmaceutical (26)
Pharmacy benefit managers (19)
Phase I (6255)
Phase II (10497)
Phase III (10681)
Pipeline (598)
Policy (49)
Postmarket research (1215)
Preclinical (1940)
Press Release (15)
Prostate cancer (69)
Psychedelics (7)
Radiopharmaceuticals (117)
Rare diseases (173)
Real estate (2025)
Recruiting (42)
Regulatory (9835)
Reports (19)
Research institute (1372)
Resumes & cover letters (424)
Rett syndrome (4)
RNA editing (1)
RSV (15)
Schizophrenia (30)
Series A (76)
Series B (48)
Service/supplier (4)
Sickle cell disease (29)
Special edition (8)
Spinal muscular atrophy (64)
Sponsored (16)
Startups (1445)
Stomach cancer (4)
Supply chain (33)
Tariffs (8)
The Weekly (4)
Vaccines (188)
Venture capitalists (13)
Weight loss (48)
Women's health (15)
Worklife (20)
Date
Today (138)
Last 7 days (405)
Last 30 days (1387)
Last 365 days (15714)
2025 (5736)
2024 (16542)
2023 (18790)
2022 (25009)
2021 (26249)
2020 (27629)
2019 (26220)
2018 (19505)
2017 (14030)
2016 (13685)
2015 (14698)
2014 (10572)
2013 (8183)
2012 (8976)
2011 (9373)
2010 (8102)
Location
Africa (489)
Alabama (29)
Alaska (6)
Arizona (102)
Arkansas (11)
Asia (13651)
Australia (2321)
California (2845)
Canada (943)
China (178)
Colorado (161)
Connecticut (121)
Delaware (73)
Europe (33892)
Florida (451)
Georgia (117)
Idaho (33)
Illinois (373)
India (12)
Indiana (189)
Iowa (6)
Japan (88)
Kansas (48)
Kentucky (20)
Louisiana (8)
Maine (29)
Maryland (427)
Massachusetts (2031)
Michigan (138)
Minnesota (170)
Mississippi (2)
Missouri (60)
Montana (8)
Nebraska (15)
Nevada (30)
New Hampshire (45)
New Jersey (974)
New Mexico (19)
New York (808)
North Carolina (558)
North Dakota (3)
Northern California (1264)
Ohio (95)
Oklahoma (9)
Oregon (19)
Pennsylvania (677)
Puerto Rico (4)
Rhode Island (21)
South America (680)
South Carolina (16)
Southern California (1035)
Tennessee (83)
Texas (450)
United States (11452)
Utah (128)
Virginia (98)
Washington D.C. (32)
Washington State (268)
West Virginia (3)
Wisconsin (48)
289,045 Results for "hoya vision care".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pfizer Advances Bold Vision for Future of Cancer Care at the ASCO 2025 Annual Meeting
April 23, 2025
·
16 min read
Press Releases
Ace Vision Group Announces Initial Close of $29.4 Million Series B Financing Round
April 24, 2025
·
2 min read
Press Releases
Mass General Brigham Releases Vision for Integrated, Patient-Centered Cancer Care
September 9, 2024
·
4 min read
Press Releases
LUMA Vision Receives FDA Clearance for VERAFEYE 2D/4D Cardiac Visualization Platform
April 16, 2025
·
3 min read
Drug development
Opthea, UNITY Fail to Unseat Regeneron’s Eylea in Vision Disorders
The Eylea franchise was in need of a win after an appellate court last week denied the pharma’s bid to block Amgen’s biosimilar from the U.S.
March 25, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Genenta Showcases Strategic Vision at Premier Biotech Forum in Qatar
April 15, 2025
·
5 min read
Press Releases
Doheny Eye Institute Announces Upcoming Presentations at the Association for Research in Vision and Ophthalmology 2025 Annual Meeting
April 16, 2025
·
4 min read
Press Releases
Iridex to Host Strategic Vision Call on April 16, 2025
April 10, 2025
·
1 min read
Press Releases
Belite Bio Announces Poster Presentations at the Association for Research in Vision and Ophthalmology 2025 Annual Meeting
April 30, 2025
·
3 min read
Press Releases
LENZ Therapeutics to Participate in Upcoming BofA Securities 2025 Health Care Conference
May 7, 2025
·
1 min read
1 of 28,905
Next
